Physician profile
Christopher T Hunter
NPI 1881913176
$7,677.83
in general payments reported to CMS, 2019-2025
10 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2021: $30.15 · 2022: $1,511 · 2023: $4,889 · 2024: $433 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,068 · Food and Beverage: $909 · Travel and Lodging: $586 · Gift: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,068.49 |
| Food and Beverage | $909.25 |
| Travel and Lodging | $586.22 |
| Gift | $182.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,678.48 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $413.76 | 2019-2025 | Phasix Mesh |
| Endogastric Solutions, INC | $137.38 | 2023 | Esophyx |
| Tela Bio, INC. | $109.15 | 2024 | Ovitex 2s |
| Ethicon US, LLC | $93.88 | 2025 | Megadyne, Echelon Endopath |
| Lilly USA, LLC | $87.03 | 2024 | Omvoh |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Zynex Medical, INC. | $52.90 | 2025 | Nexwave |
| Asensus Surgical, INC. | $22.80 | 2019 | |
| Integra Lifesciences Corporation | $13.96 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.